University of California San Francisco

Tobias Deuse, MD

Dr. Tobias Deuse
Tobias Deuse, MD

Professor of Surgery
The Julien I.E. Hoffman, M.D. Endowed Chair in Cardiac Surgery
Principal Investigator, TSI Lab
Division of Cardiac Surgery & Lung Transplantation
Department of Surgery, School of Medicine
University of California, San Francisco
Director, Minimally-Invasive Cardiac Surgery, UCSF Health
Surgical Director, Transcatheter Valve Program, UCSF Health
 

Academic Office:
500 Parnassus Ave, MUW 405, Box 0118
San Francisco, CA 94143-0118
Tel: (415) 353-8890
Email: [email protected] 
Admin: [email protected] 

Cardiac Surgery Program
400 Parnassus Avenue, Suite 501, Box 0957
San Francisco, California,  94143
Tel:415-353-1606
Fax: 415-353-1312

    Biography

    Dr. Tobias Deuse is a heart surgeon and the director of minimally invasive cardiac surgery at UCSF. He is known for his pioneering work in developing minimally invasive techniques for mitral valve repair.

    Deuse earned his medical degree from the University of Würzburg in Germany. He received advanced training in heart and lung surgery at the University Hospital of Munich and University Heart Center Hamburg. After obtaining board certification in Germany as a heart surgeon, he completed a fellowship in lung and heart-lung transplantation with Stanford Medicine.

    After returning to Germany in 2009, Deuse was appointed director of heart and lung transplantation at the University Heart Center Hamburg. He achieved international acclaim for his development of innovative approaches to heart failure surgery, most notably minimally invasive techniques for implanting ventricular assist systems. He also demonstrated that high success rates could be achieved in mitral valve repair utilizing fully robot-assisted endoscopic surgery. Also known as keyhole surgery, this approach has many benefits for the patient, including substantially reduced postsurgical pain, shorter hospital stays and faster recovery.

    Deuse has received numerous honors, including election to the board of directors of the International Society for Heart and Lung Transplantation.

    Education

    Institution Degree Dept or School End Date
    University of California Diversity, Equity, and Inclusion Champion Training 2019

    Collaboration Interests

    I am interested in:

    • physician scientist

    Clinical Expertise

    Minimally Invasive Mitral Valve Surgery

    Minimally Invasive Aortic Valve Surgery

    Minimally Invasive Atrial Septal Defect (ASD) Closure

    Aortic Valve Repair & Replacement

    Acute Aortic Dissection Repair

    Heart Transplantation

    Lung Transplantation

    Ventricular Assist Devices (VAD)

    Ventricular Aneurysm

    Arrhythmia

    Coronary Artery Bypass Grafting (CABG)

    Off-Pump Coronary Artery Bypass (OPCAB)

    Program Affiliations

    UCSF Heart & Vascular Center

    Grants and Funding

    • Hypo-immunogenic cardiomyocytes for myocardial repair | NIH | 2018-08-01 - 2022-06-30 | Role: Principal Investigator
    • Microgravity as model for immunological senescence and its impact on tissue stem cells and regeneration | NIH | 2017-06-15 - 2022-06-30 | Role: Co-Principal Investigator
    • Microgravity as model for immunological senescence and its impact on tissue stem cells and regeneration | NIH | 2017-06-15 - 2020-02-29 | Role: Co-Principal Investigator

    Research Narrative

    Dr. Deuse's research is focused on vascular biology and pathophysiology. His group was the among the first to elucdiate the novel pathways involved in the development of vascular intimal hyperplasia. Myointimal hyperplasia is a pathological process of the vascular system characterized by abnormal proliferation of smooth muscle cells of the vascular wall that leads to luminal obliteration and subsequent ischemia.

    Myointimal hyperplasia may occur in patients after vessel injury during medical procedures (e.g. after balloon dilation or stent placement) or after pathological injury of the blood vessel (e.g. due to inflammation or toxic exposure). It can cause bypass graft failure and in-stent restenosis. To help prevent this and increase the success of treatments for vascular disease including coronary heart disease, his research group is working on the development of new preventive drug regimes and strategies.

    Research Interests

    Vascular Biology

    Stem Cell Immunobiology

    Transplant Immunology

    Oxidative Stress and Apoptosis

    Pulmonary Hypertension

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 137
    1. Allogeneic Beta Cells with No Immunosuppression. Reply.
      Carlsson PO, Deuse T, Schrepfer S| | PubMed
    2. Hypoimmune CD19 CAR T cells evade allorejection in patients with cancer and autoimmune disease.
      Hu X, Beauchesne P, Wang C, Wong A, Deuse T, Schrepfer S, ARDENT and GLEAM investigators| | PubMed
    3. Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression.
      Carlsson PO, Hu X, Scholz H, Ingvast S, Lundgren T, Scholz T, Eriksson O, Liss P, Yu D, Deuse T, Korsgren O, Schrepfer S| | PubMed
    4. Hypoimmune FK binding protein 12-knockout CD19 CAR T cells achieve deep tissue B-cell depletion and control Nalm6 tumors in immunosuppressed humanized mice.
      Hu X, McAlister A, Kinder J, Johnson A, White K, Caruso CB, Wang C, Basco R, Gattis C, Friera A, Deuse T, Schrepfer S| | PubMed
    5. Hypoimmune CD19 CAR T cells treat allogeneic mice with features of spontaneous systemic lupus erythematosus.
      Hu X, White K, Olroyd AG, Friera A, Wang C, Caruso CB, Connolly AJ, Deuse T, Schrepfer S| | PubMed
    6. Inhibition of polymorphonuclear cells averts cytotoxicity against hypoimmune cells in xenotransplantation.
      Hu X, Tediashvili G, Gravina A, Stoddard J, McGill TJ, Connolly AJ, Deuse T, Schrepfer S| | PubMed
    7. Progress and challenges in developing allogeneic cell therapies.
      Deuse T, Schrepfer S| | PubMed
    8. Hydroxocobalamin for the treatment of vasoplegia after lung transplantation: A case series.
      Nguyen A, Bouajram R, Brzezinski M, Hassanipour S, Gordon D, Trinh B, Deuse T, Venado A, Hays S, Singer J, Kukreja J| | PubMed
    9. The HIP mouse and all of its organs are completely invisible to allogeneic immune cells.
      Hu X, White K, Olroyd AG, Wang C, Caruso CB, Gattis C, Young C, Connolly AJ, Deuse T, Schrepfer S| | PubMed
    10. Clinical Improvement With Transcatheter Edge-to-Edge Tricuspid Repair Irrespective of Right Atrial Pressure.
      Ya'Qoub L, Caughron H, Qasim A, Tolstrop K, Delling FN, Watt C, Nguyen T, Deuse T, Beygui RE, Mahadevan VS| | PubMed
    11. Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression.
      Gravina A, Tediashvili G, Rajalingam R, Quandt Z, Deisenroth C, Schrepfer S, Deuse T| | PubMed
    12. Intercostal Nerve Cryoanalgesia Versus Thoracic Epidural Analgesia in Lung Transplantation: A Retrospective Single-Center Study.
      Isaza E, Santos J, Haro GJ, Chen J, Weber DJ, Deuse T, Singer JP, Golden JA, Hays S, Trinh BN, Brzezinski M, Kukreja J| | PubMed
    13. The SIRPα-CD47 immune checkpoint in NK cells.
      Deuse T, Hu X, Agbor-Enoh S, Jang MK, Alawi M, Saygi C, Gravina A, Tediashvili G, Nguyen VQ, Liu Y, Valantine H, Lanier LL, Schrepfer S| | PubMed
    14. Subxiphoid Hybrid Epicardial-Endocardial Atrial Fibrillation Ablation and LAA Ligation: Initial Sub-X Hybrid MAZE Registry Results.
      Ellis CR, Badhwar N, Tschopp D, Danter M, Jackson GG, Kerendi F, Walters T, Fang Q, Deuse T, Beygui R, Lee RJ| | PubMed
    15. Impact of Aortic Stenosis on Myofiber Stress: Translational Application of Left Ventricle-Aortic Coupling Simulation.
      Wisneski AD, Wang Y, Deuse T, Hill AC, Pasta S, Sack KL, Yao J, Guccione JM| | PubMed
    16. The H-Y Antigen in Embryonic Stem Cells Causes Rejection in Syngeneic Female Recipients.
      Hu X, Kueppers ST, Kooreman NG, Gravina A, Wang D, Tediashvili G, Schlickeiser S, Frentsch M, Nikolaou C, Thiel A, Marcus S, Fuchs S, Velden J, Reichenspurner H, Volk HD, Deuse T, Schrepfer S| | PubMed
    17. Risk Factors and Outcomes of Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation.
      Kukreja J, Tsou S, Chen J, Trinh BN, Feng C, Golden JA, Hays S, Deuse T, Singer JP, Brzezinski M| | PubMed
    18. Frailty after lung transplantation is associated with impaired health-related quality of life and mortality.
      Venado A, Kolaitis NA, Huang CY, Gao Y, Glidden DV, Soong A, Sutter N, Katz PP, Greenland JR, Calabrese DR, Hays SR, Golden JA, Shah RJ, Leard LE, Kukreja J, Deuse T, Wolters PJ, Covinsky K, Blanc PD, Singer JP| | PubMed
    19. Impact of donor lung quality on post-transplant recipient outcome in the Lung Allocation Score era in Eurotransplant - a historical prospective study.
      Smits JM, Gottlieb J, Verschuuren E, Evrard P, Hoek R, Knoop C, Lang G, Kwakkel-van Erp JM, Vos R, Verleden G, Rondelet B, Hoefer D, Langer F, Schramm R, Hoetzenecker K, van Kessel D, Luijk B, Seghers L, Deuse T, Buhl R, Witt C, Strelniece A, Green D, de Vries E, Laufer G, Van Raemdonck D| | PubMed
    20. A Cryoinjury Model to Study Myocardial Infarction in the Mouse.
      Wang D, Tediashvili G, Hu X, Gravina A, Marcus SG, Zhang H, Olgin JE, Deuse T, Schrepfer S| | PubMed
    21. De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans.
      Deuse T, Hu X, Agbor-Enoh S, Koch M, Spitzer MH, Gravina A, Alawi M, Marishta A, Peters B, Kosaloglu-Yalcin Z, Yang Y, Rajalingam R, Wang D, Nashan B, Kiefmann R, Reichenspurner H, Valantine H, Weissman IL, Schrepfer S| | PubMed
    22. Bergeyella cardium: Clinical Characteristics and Draft Genome of an Emerging Pathogen in Native and Prosthetic Valve Endocarditis.
      Mulliken JS, Langelier C, Budak JZ, Miller S, Dynerman D, Hao S, Li LM, Crawford E, Lyden A, Woodworth MH, DeRisi JL, Desmond E, Browne C, Luu A, Grandis DJ, Grossman W, Deuse T, Melcher GP| | PubMed
    23. Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.
      Deuse T, Hu X, Gravina A, Wang D, Tediashvili G, De C, Thayer WO, Wahl A, Garcia JV, Reichenspurner H, Davis MM, Lanier LL, Schrepfer S| | PubMed
    24. Nontyphoidal Salmonella as a Cause of Mediastinal Abscess after Aortic Valve Replacement: A Case Report and Review of Postoperative Salmonella Infections.
      Spottiswoode N, Peluso MJ, Deuse T, Babik JM| | PubMed
    25. Analysis of Minimally Invasive Left Thoracotomy HVAD Implantation - A Single-Center Experience.
      Reichart D, Brand CF, Bernhardt AM, Schmidt S, Schaefer A, Blankenberg S, Reichenspurner H, Wagner FM, Deuse T, Barten MJ| | PubMed
    26. Lung allocation score: the Eurotransplant model versus the revised US model - a cross-sectional study.
      Smits JM, Nossent G, Evrard P, Lang G, Knoop C, Kwakkel-van Erp JM, Langer F, Schramm R, van de Graaf E, Vos R, Verleden G, Rondelet B, Hoefer D, Hoek R, Hoetzenecker K, Deuse T, Strelniece A, Green D, de Vries E, Samuel U, Laufer G, Buhl R, Witt C, Gottlieb J| | PubMed
    27. Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study.
      Warnecke G, Van Raemdonck D, Smith MA, Massard G, Kukreja J, Rea F, Loor G, De Robertis F, Nagendran J, Dhital KK, Moradiellos Díez FJ, Knosalla C, Bermudez CA, Tsui S, McCurry K, Wang IW, Deuse T, Lesèche G, Thomas P, Tudorache I, Kühn C, Avsar M, Wiegmann B, Sommer W, Neyrinck A, Schiavon M, Calabrese F, Santelmo N, Olland A, Falcoz PE, Simon AR, Varela A, Madsen JC, Hertz M, Haverich A, Ardehali A| | PubMed
    28. Hybrid Open Minimally Invasive Transcatheter Mitral Valve Replacement.
      Marcus SG, Mahadevan VS, Deuse T| | PubMed
    29. Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta.
      Tediashvili G, Wang D, Reichenspurner H, Deuse T, Schrepfer S| | PubMed
    30. Hybrid and surgical procedures for the treatment of persistent and longstanding persistent atrial fibrillation.
      Sanchez JM, Al-Dosari G, Chu S, Beygui R, Deuse T, Badhwar N, Lee RJ| | PubMed
    31. Outcomes of Minimally Invasive Temporary Right Ventricular Assist Device Support for Acute Right Ventricular Failure During Minimally Invasive Left Ventricular Assist Device Implantation.
      Schaefer A, Reichart D, Bernhardt AM, Kubik M, Barten MJ, Wagner FM, Reichenspurner H, Philipp SA, Deuse T| | PubMed
    32. Thalidomide treatment prevents chronic graft rejection after aortic transplantation in rats - an experimental study.
      Miller KK, Wang D, Hu X, Hua X, Deuse T, Neofytou E, Renne T, Velden J, Reichenspurner H, Schrepfer S, Bernstein D| | PubMed
    33. Differences in Vascular Response between Balloon Overstretch and Stent Overexpansion in Nonatherosclerotic Porcine Coronary Arteries.
      Mitsutake Y, Reifart J, Pyun WB, Lyons JK, Deuse T, Schrepfer S, Ikeno F| | PubMed
    34. Gender differences and outcomes in left ventricular assist device support: The European Registry for Patients with Mechanical Circulatory Support.
      Magnussen C, Bernhardt AM, Ojeda FM, Wagner FM, Gummert J, de By TMMH, Krabatsch T, Mohacsi P, Rybczynski M, Knappe D, Sill B, Deuse T, Blankenberg S, Schnabel RB, Reichenspurner H| | PubMed
    35. The value of fluorine-18 deoxyglucose positron emission tomography scans in patients with ventricular assist device specific infections†.
      Bernhardt AM, Pamirsad MA, Brand C, Reichart D, Tienken M, Barten MJ, Schaefer A, Grahn H, Rybczynski M, Deuse T, Reichenspurner H, Wagner FM| | PubMed
    36. Lobar lung transplantation from deceased donors: A systematic review.
      Eberlein M, Reed RM, Chahla M, Bolukbas S, Blevins A, Van Raemdonck D, Stanzi A, Inci I, Marasco S, Shigemura N, Aigner C, Deuse T| | PubMed
    37. Vein Interposition Model: A Suitable Model to Study Bypass Graft Patency.
      Wang D, Tediashvili G, Pecha S, Reichenspurner H, Deuse T, Schrepfer S| | PubMed
    38. Orthotopic tracheal transplantation using human bronchus: an original xenotransplant model of obliterative airway disorder.
      Guihaire J, Itagaki R, Stubbendorff M, Hua X, Deuse T, Ullrich S, Fadel E, Dorfmüller P, Robbins RC, Reichenspurner H, Schumacher U, Schrepfer S| | PubMed
    39. Acute Pulmonary Artery Obstruction as the Primary Manifestation of a Rapidly Growing Intimal Sarcoma in a 54-Year-Old Patient.
      Westhofen S, Kugler C, Reichenspurner H, Deuse T| | PubMed
    40. A matched pairs analysis of non-rib-spreading, fully endoscopic, mini-incision technique versus conventional mini-thoracotomy for mitral valve repair.
      Westhofen S, Conradi L, Deuse T, Detter C, Vettorazzi E, Treede H, Reichenspurner H| | PubMed
    41. The Selective JAK1/3-Inhibitor R507 Mitigates Obliterative Airway Disease Both With Systemic Administration and Aerosol Inhalation.
      Deuse T, Hua X, Stubbendorff M, Spin JM, Neofytou E, Taylor V, Chen Y, Park G, Fink JB, Renne T, Kiefmann M, Kiefmann R, Reichenspurner H, Robbins RC, Schrepfer S| | PubMed
    42. The MANDELA study: A multicenter, randomized, open-label, parallel group trial to refine the use of everolimus after heart transplantation.
      Deuse T, Bara C, Barten MJ, Hirt SW, Doesch AO, Knosalla C, Grinninger C, Stypmann J, Garbade J, Wimmer P, May C, Porstner M, Schulz U| | PubMed
    43. Sex Differences in Immunology: More Severe Development of Experimental Pulmonary Hypertension in Male Rats Exposed to Vascular Endothelial Growth Factor Receptor Blockade.
      Guihaire J, Deuse T, Wang D, Fadel E, Reichenspurner H, Schrepfer S| | PubMed
    44. Distal Airway Stem Cells are Essential for Lung Regeneration.
      Deuse T, Schrepfer S| | PubMed
    45. Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent Restenosis.
      Wang D, Deuse T, Stubbendorff M, Chernogubova E, Erben RG, Eken SM, Jin H, Li Y, Busch A, Heeger CH, Behnisch B, Reichenspurner H, Robbins RC, Spin JM, Tsao PS, Schrepfer S, Maegdefessel L| | PubMed
    46. Mesenchymal stromal cell therapy: different sources exhibit different immunobiological properties.
      Neofytou E, Deuse T, Beygui RE, Schrepfer S| | PubMed
    47. Immunobiology of fibrin-based engineered heart tissue.
      Conradi L, Schmidt S, Neofytou E, Deuse T, Peters L, Eder A, Hua X, Hansen A, Robbins RC, Beygui RE, Reichenspurner H, Eschenhagen T, Schrepfer S| | PubMed
    48. Concomitant minimally invasive HVAD and transapical aortic valve implantation.
      Schaefer A, Treede H, Bernhardt A, Wagner FM, Reichenspurner H, Deuse T| | PubMed
    49. SCNT-derived ESCs with mismatched mitochondria trigger an immune response in allogeneic hosts.
      Deuse T, Wang D, Stubbendorff M, Itagaki R, Grabosch A, Greaves LC, Alawi M, Grünewald A, Hu X, Hua X, Velden J, Reichenspurner H, Robbins RC, Jaenisch R, Weissman IL, Schrepfer S| | PubMed
    50. Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression.
      Zuckermann A, Schulz U, Deuse T, Ruhpawar A, Schmitto JD, Beiras-Fernandez A, Hirt S, Schweiger M, Kopp-Fernandes L, Barten MJ| | PubMed
    51. Isolated permanent right ventricular assist device implantation with the HeartWare continuous-flow ventricular assist device: first results from the European Registry for Patients with Mechanical Circulatory Support.
      Bernhardt AM, De By TM, Reichenspurner H, Deuse T| | PubMed
    52. Clinical experience of combined HeartWare ventricular assist device and implantable cardioverter defibrillator therapy.
      Pecha S, Wilke I, Bernhardt A, Hakmi S, Yildirim Y, Steven D, Reichenspurner H, Willems S, Deuse T, Aydin A| | PubMed
    53. HVAD implantation in right atrium-to-right pulmonary artery configuration.
      Deuse T, Kubik M, Reichenspurner H| | PubMed
    54. Introduction of the lung allocation score in Germany.
      Gottlieb J, Greer M, Sommerwerck U, Deuse T, Witt C, Schramm R, Hagl C, Strueber M, Smits JM| | PubMed
    55. Inducing myointimal hyperplasia versus atherosclerosis in mice: an introduction of two valid models.
      Stubbendorff M, Hua X, Deuse T, Ali Z, Reichenspurner H, Maegdefessel L, Robbins RC, Schrepfer S| | PubMed
    56. Dichloroacetate prevents restenosis in preclinical animal models of vessel injury.
      Deuse T, Hua X, Wang D, Maegdefessel L, Heeren J, Scheja L, Bolaños JP, Rakovic A, Spin JM, Stubbendorff M, Ikeno F, Länger F, Zeller T, Schulte-Uentrop L, Stoehr A, Itagaki R, Haddad F, Eschenhagen T, Blankenberg S, Kiefmann R, Reichenspurner H, Velden J, Klein C, Yeung A, Robbins RC, Tsao PS, Schrepfer S| | PubMed
    57. Minimally invasive implantation of biventricular assist devices.
      Deuse T, Reichenspurner H| | PubMed
    58. Do not touch the sternum--thoracotomy incisions for HVAD implantation.
      Deuse T, Reichenspurner H| | PubMed
    59. Efficacy of prophylactic intra-aortic balloon pump therapy in chronic heart failure patients undergoing cardiac surgery.
      Yildirim Y, Pecha S, Kubik M, Alassar Y, Deuse T, Hakmi S, Reichenspurner H| | PubMed
    60. Dual-chamber pacemaker implantation with left ventricular pacing in a patient with a right ventricular assist device.
      Sill B, Reichenspurner H, Deuse T| | PubMed
    61. HVAD continuous flow assist device for ischemic ventricular septal rupture.
      Bernhardt AM, Reichenspurner H, Deuse T| | PubMed
    62. Mechanically induced ventricular tachycardia by the HeartWare ventricular assist device.
      Yildirim Y, Pecha S, Reichenspurner H, Deuse T| | PubMed
    63. Everolimus in heart transplantation: an update.
      Hirt SW, Bara C, Barten MJ, Deuse T, Doesch AO, Kaczmarek I, Schulz U, Stypmann J, Haneya A, Lehmkuhl HB| | PubMed
    64. Bortezomib rescue therapy in a patient with recurrent antibody-mediated rejection after lung transplantation.
      Baum C, Reichenspurner H, Deuse T| | PubMed
    65. Granulocyte colony-stimulating factor therapy is associated with a reduced incidence of acute rejection episodes or allograft vasculopathy in heart transplant recipients.
      Vrtovec B, Haddad F, Pham M, Deuse T, Fearon WF, Schrepfer S, Leon S, Vu T, Valantine H, Hunt SA| | PubMed
    66. Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue.
      Stubbendorff M, Deuse T, Hua X, Phan TT, Bieback K, Atkinson K, Eiermann TH, Velden J, Schröder C, Reichenspurner H, Robbins RC, Volk HD, Schrepfer S| | PubMed
    67. Minimal access median sternotomy for aortic valve replacement in elderly patients.
      Alassar Y, Yildirim Y, Pecha S, Detter C, Deuse T, Reichenspurner H| | PubMed
    68. Isolated permanent right ventricular assistance using the HVAD continuous-flow pump.
      Deuse T, Schirmer J, Kubik M, Reichenspurner H| | PubMed
    69. Aspergillus galactomannan antigen for diagnosis and treatment monitoring in cerebral aspergillosis.
      Soeffker G, Wichmann D, Loderstaedt U, Sobottka I, Deuse T, Kluge S| | PubMed
    70. ST-elevation myocardial infarction following heart transplantation as an unusual presentation of coronary allograft vasculopathy: a case report.
      Peter S, Hulme O, Deuse T, Vrtovec B, Fearon WF, Hunt S, Haddad F| | PubMed
    71. The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.
      Hua X, Deuse T, Chen YJ, Wulff H, Stubbendorff M, Köhler R, Miura H, Länger F, Reichenspurner H, Robbins RC, Schrepfer S| | PubMed
    72. Severe bacterial superinfection based on influenza A (H1N1) pneumonia in a heart-lung transplant recipient.
      Yildirim Y, Pecha S, Sill B, Deuse T, Reichenspurner H| | PubMed
    73. Concomitant transcatheter aortic valve and left ventricular assist device implantation.
      Baum C, Seiffert M, Treede H, Reichenspurner H, Deuse T| | PubMed
    74. Late profound muscle weakness following heart transplantation due to Danon disease.
      Van Der Starre P, Deuse T, Pritts C, Brun C, Vogel H, Oyer P| | PubMed
    75. Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545.
      Deuse T, Hua X, Taylor V, Stubbendorff M, Baluom M, Chen Y, Park G, Velden J, Streichert T, Reichenspurner H, Robbins RC, Schrepfer S| | PubMed
    76. Clinical and functional correlates of early microvascular dysfunction after heart transplantation.
      Haddad F, Khazanie P, Deuse T, Weisshaar D, Zhou J, Nam CW, Vu TA, Gomari FA, Skhiri M, Simos A, Schnittger I, Vrotvec B, Hunt SA, Fearon WF| | PubMed
    77. Successful extracorporeal membrane oxygenation weaning after cardiac resynchronization therapy device implantation in a patient with end-stage heart failure.
      Pecha S, Yildirim Y, Reichenspurner H, Deuse T| | PubMed
    78. Human internal mammary artery (IMA) transplantation and stenting: a human model to study the development of in-stent restenosis.
      Hua X, Deuse T, Michelakis ED, Haromy A, Tsao PS, Maegdefessel L, Erben RG, Bergow C, Behnisch BB, Reichenspurner H, Robbins RC, Schrepfer S| | PubMed
    79. Cardiac paraganglioma: diagnostic and surgical challenges.
      Huo JL, Choi JC, DeLuna A, Lee D, Fleischmann D, Berry GJ, Deuse T, Haddad F| | PubMed
    80. Human leukocyte antigen I knockdown human embryonic stem cells induce host ignorance and achieve prolonged xenogeneic survival.
      Deuse T, Seifert M, Phillips N, Fire A, Tyan D, Kay M, Tsao PS, Hua X, Velden J, Eiermann T, Volk HD, Reichenspurner H, Robbins RC, Schrepfer S| | PubMed
    81. Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells.
      Deuse T, Seifert M, Phillips N, Fire A, Tyan D, Kay M, Tsao PS, Hua X, Velden J, Eiermann T, Volk HD, Reichenspurner H, Robbins RC, Schrepfer S| | PubMed
    82. Surgical technique of lower lobe lung transplantation.
      Deuse T, Sill B, von Samson P, Yildirim Y, Kugler C, Oldigs M, Klose H, Meierling S, Rabe KF, Reichenspurner H| | PubMed
    83. Bioluminescence imaging for assessment of immune responses following implantation of engineered heart tissue (EHT).
      Conradi L, Pahrmann C, Schmidt S, Deuse T, Hansen A, Eder A, Reichenspurner H, Robbins RC, Eschenhagen T, Schrepfer S| | PubMed
    84. Minimally invasive resection of a right atrial mass in a cardiac transplant recipient: a case report.
      Conradi L, Deuse T, Treede H, Seiffert M, Adam M, Koelble K, Costard-Jaeckle A, Wagner FM, Reichenspurner H| | PubMed
    85. Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients.
      Meyer S, Adam M, Schweiger B, Ilchmann C, Eulenburg C, Sattinger E, Runte H, Schlüter M, Deuse T, Reichenspurner H, Costard-Jäckle A| | PubMed
    86. Orthotopic aortic transplantation: a rat model to study the development of chronic vasculopathy.
      Stubbendorff M, Deuse T, Hammel A, Robbins RC, Reichenspurner H, Schrepfer S| | PubMed
    87. Transcatheter aortic valve implantation in a heart transplant recipient: a case report.
      Seiffert M, Meyer S, Franzen O, Conradi L, Baldus S, Schirmer J, Deuse T, Costard-Jaeckle A, Reichenspurner H, Treede H| | PubMed
    88. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells.
      Deuse T, Stubbendorff M, Tang-Quan K, Phillips N, Kay MA, Eiermann T, Phan TT, Volk HD, Reichenspurner H, Robbins RC, Schrepfer S| | PubMed
    89. Sustained inhibition of epsilon protein kinase C inhibits vascular restenosis after balloon injury and stenting.
      Deuse T, Koyanagi T, Erben RG, Hua X, Velden J, Ikeno F, Reichenspurner H, Robbins RC, Mochly-Rosen D, Schrepfer S| | PubMed
    90. Review of heart-lung transplantation at Stanford.
      Deuse T, Sista R, Weill D, Tyan D, Haddad F, Dhillon G, Robbins RC, Reitz BA| | PubMed
    91. Non-volume-loaded heart provides a more relevant heterotopic transplantation model.
      Tang-Quan KR, Bartos J, Deuse T, Churchill E, Schäfer H, Reichenspurner H, Mochly-Rosen D, Robbins RC, Schrepfer S| | PubMed
    92. Heterotopic and orthotopic tracheal transplantation in mice used as models to study the development of obliterative airway disease.
      Hua X, Deuse T, Tang-Quan KR, Robbins RC, Reichenspurner H, Schrepfer S| | PubMed
    93. Asymptomatic infection with novel influenza A/H1N1 virus in a heart transplant recipient.
      Meyer S, Ilchmann C, Adam M, Sattinger E, Siamkouris D, Arunagirinathan U, Deuse T, Wagner FM, Reichenspurner H, Costard-Jaeckle A| | PubMed
    94. Mechanisms behind local immunosuppression using inhaled tacrolimus in preclinical models of lung transplantation.
      Deuse T, Blankenberg F, Haddad M, Reichenspurner H, Phillips N, Robbins RC, Schrepfer S| | PubMed
    95. Changing trends in infectious disease in heart transplantation.
      Haddad F, Deuse T, Pham M, Khazanie P, Rosso F, Luikart H, Valantine H, Leon S, Vu TA, Hunt SA, Oyer P, Montoya JG| | PubMed
    96. LAD-ligation: a murine model of myocardial infarction.
      Kolk MV, Meyberg D, Deuse T, Tang-Quan KR, Robbins RC, Reichenspurner H, Schrepfer S| | PubMed
    97. Alternative technique for salvage of donor lungs with insufficient atrial cuffs.
      Yarbrough WM, Bates MJ, Deuse T, Tang DG, Robbins RC, Reitz BA, Mallidi HR| | PubMed
    98. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
      Deuse T, Peter C, Fedak PW, Doyle T, Reichenspurner H, Zimmermann WH, Eschenhagen T, Stein W, Wu JC, Robbins RC, Schrepfer S| | PubMed
    99. Imaging in-stent restenosis: an inexpensive, reliable, and rapid preclinical model.
      Deuse T, Ikeno F, Robbins RC, Schrepfer S| | PubMed
    100. Heart-lung transplantation in situs inversus totalis.
      Deuse T, Reitz BA| | PubMed
    101. Right ventricular dysfunction predicts poor outcome following hemodynamically compromising rejection.
      Haddad F, Fisher P, Pham M, Berry G, Weisshaar D, Kuppahally S, Vrtovec B, Deuse T, Virani S, Fearon W, Valantine H, Hunt S| | PubMed
    102. A novel JAK3 inhibitor, R348, attenuates chronic airway allograft rejection.
      Velotta JB, Deuse T, Haddad M, Masuda E, Park G, Carroll D, Taylor V, Robbins RC, Schrepfer S| | PubMed
    103. Heart transplantation in situs inversus totalis.
      Deuse T, Reitz BA| | PubMed
    104. Twenty-year survivors of heart transplantation at Stanford University.
      Deuse T, Haddad F, Pham M, Hunt S, Valantine H, Bates MJ, Mallidi HR, Oyer PE, Robbins RC, Reitz BA| | PubMed
    105. Novel immunosuppression: R348, a JAK3- and Syk-inhibitor attenuates acute cardiac allograft rejection.
      Deuse T, Velotta JB, Hoyt G, Govaert JA, Taylor V, Masuda E, Herlaar E, Park G, Carroll D, Pelletier MP, Robbins RC, Schrepfer S| | PubMed
    106. Prevention and inhibition but not reversion of chronic allograft vasculopathy by FK778.
      Deuse T, Hoyt G, Koyanagi T, Robbins RC, Schrepfer S| | PubMed
    107. Introducing the first polymer-free leflunomide eluting stent.
      Deuse T, Erben RG, Ikeno F, Behnisch B, Boeger R, Connolly AJ, Reichenspurner H, Bergow C, Pelletier MP, Robbins RC, Schrepfer S| | PubMed
    108. Fluoroscopy to assess late heart and lung perforation by a permanent ventricular pacemaker lead. A case complicated by isolated hemothorax.
      Mortensen K, Aydin MA, Goldmann B, Deuse T, Willems S, Ventura R| | PubMed
    109. Effect of inhaled tacrolimus on cellular and humoral rejection to prevent posttransplant obliterative airway disease.
      Schrepfer S, Deuse T, Reichenspurner H, Hoffmann J, Haddad M, Fink J, Fischbein MP, Robbins RC, Pelletier MP| | PubMed
    110. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
      Deuse T, Schrepfer S, Pelletier MP, Fischbein MP, Robbins RC, Reichenspurner H| | PubMed
    111. Stem cell transplantation: the lung barrier.
      Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP| | PubMed
    112. Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?
      Deuse T, Schrepfer S, Reichenspurner H, Hoyt G, Fischbein MP, Robbins RC, Pelletier MP| | PubMed
    113. Simplified protocol to isolate, purify, and culture expand mesenchymal stem cells.
      Schrepfer S, Deuse T, Lange C, Katzenberg R, Reichenspurner H, Robbins RC, Pelletier MP| | PubMed
    114. Experimental orthotopic tracheal transplantation: The Stanford technique.
      Schrepfer S, Deuse T, Hoyt G, Sheikh AY, Hoffmann J, Reichenspurner H, Robbins RC, Pelletier MP| | PubMed
    115. FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy.
      Schrepfer S, Deuse T, Koch-Nolte F, Krieger T, Haddad M, Schäfer H, Pelletier MP, Robbins RC, Reichenspurner H| | PubMed
    116. Inhibition of restenosis development after mechanical injury: a new field of application for malononitrilamides?
      Schrepfer S, Deuse T, Sultan KR, Haddad M, Böger R, Münzel T, Schäfer H, Pelletier MP, Robbins RC, Reichenspurner H| | PubMed
    117. The selective estrogen receptor-beta agonist biochanin A shows vasculoprotective effects without uterotrophic activity.
      Schrepfer S, Deuse T, Münzel T, Schäfer H, Braendle W, Reichenspurner H| | PubMed
    118. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase.
      Baldus S, Rudolph V, Roiss M, Ito WD, Rudolph TK, Eiserich JP, Sydow K, Lau D, Szöcs K, Klinke A, Kubala L, Berglund L, Schrepfer S, Deuse T, Haddad M, Risius T, Klemm H, Reichenspurner HC, Meinertz T, Heitzer T| | PubMed
    119. FK778: new cellular and molecular mechanisms of action.
      Schrepfer S, Deuse T, Koch-Nolte F, Detter C, Reichenspurner H| | PubMed
    120. Sirolimus and FK778: a comparison of two anti-proliferative immunosuppressants for prevention of experimental obliterative airway disease.
      Deuse T, Schrepfer S, Koch-Nolte F, Haddad M, Schäfer H, Detter C, Reichenspurner H| | PubMed
    121. Tracheal allograft transplantation in rats: the role of different immunosuppressants on preservation of respiratory epithelium.
      Schrepfer S, Deuse T, Sydow K, Schäfer H, Detter C, Reichenspurner H| | PubMed
    122. The phytoestrogen biochaninA weakens acute cardiac allograft rejection without affecting the reproductive system.
      Schrepfer S, Deuse T, Schäfer H, Koch-Nolte F, Braendle W, Reichenspurner H| | PubMed
    123. FK778 and tacrolimus prevent the development of obliterative airway disease after heterotopic rat tracheal transplantation.
      Deuse T, Schrepfer S, Koch-Nolte F, Haddad M, Schwedhelm E, Böger R, Schäfer H, Detter C, Reichenspurner H| | PubMed
    124. FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival.
      Schrepfer S, Deuse T, Schäfer H, Reichenspurner H| | PubMed
    125. Video and robotic-assisted minimally invasive mitral valve surgery: a comparison of the Port-Access and transthoracic clamp techniques.
      Reichenspurner H, Detter C, Deuse T, Boehm DH, Treede H, Reichart B| | PubMed
    126. FK778 attenuates lymphocyte-endothelium interaction after cardiac transplantation: in vivo and in vitro studies.
      Deuse T, Schrepfer S, Schäfer H, Koch-Nolte F, Schwedhelm E, Böger RH, Reichenspurner H| | PubMed
    127. The interaction between FK778 and tacrolimus in the prevention of rat cardiac allograft rejection is dose dependent.
      Deuse T, Schrepfer S, Reichenspurner H| | PubMed
    128. Immunosuppression with FK778 and mycophenolate mofetil in a rat cardiac transplantation model.
      Deuse T, Schrepfer S, Reichenspurner H| | PubMed
    129. Successful resection of a symptomatic right ventricular lipoma.
      Schrepfer S, Deuse T, Detter C, Treede H, Koops A, Boehm DH, Willems S, Lacour-Gayet F, Reichenspurner H| | PubMed
    130. Robotically assisted coronary artery bypass surgery with the ZEUS telemanipulator system.
      Boehm DH, Detter C, Arnold MB, Deuse T, Reichenspurner H| | PubMed
    131. Correlation between mononuclear infiltration and changes in VASP phosphorylation patterns after heterotopic cardiac transplantation in the rat.
      Deuse T, Lange V, Schrepfer S, Eigenthaler M, Reichart B, Walter U, Elert O| | PubMed
    132. Early and midterm results after coronary artery bypass grafting with and without cardiopulmonary bypass: which patient population benefits the most?
      Deuse T, Detter C, Samuel V, Boehm DH, Reichenspurner H, Reichart B| | PubMed
    133. New technique for chest opening in mice: U-sternotomy.
      Schrepfer S, Deuse T, Reichenspurner H| | PubMed
    134. Midterm results and quality of life after minimally invasive vs. conventional aortic valve replacement.
      Detter C, Deuse T, Boehm DH, Reichenspurner H, Reichart B| | PubMed
    135. Comparison of two stabilizer concepts for off-pump coronary artery bypass grafting.
      Detter C, Deuse T, Christ F, Boehm DH, Reichenspurner H, Reichart B| | PubMed
    136. Robotically-assisted coronary artery surgery with and without cardiopulmonary bypass - from first clinical use to endoscopic operation.
      Detter C, Boehm DH, Reichenspurner H, Deuse T, Arnold M, Reichart B| | PubMed
    137. Effect of hemodynamics on graft rejection in the heterotopic heart transplantation model.
      Lange V, Gassel AM, Deuse T, Ulrichs K, Silber RE| | PubMed